<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><atom:link href="https://www.dovepress.com/feed/journal/102" rel="self" type="application/rss+xml"/><title>Gastrointestinal Cancer: Targets and Therapy</title><link>https://www.dovepress.com/feed/journal/102</link><description>New articles released by Dove Press for Gastrointestinal Cancer: Targets and Therapy</description><language>en-us</language><copyright>2026, Dove Press</copyright><webMaster>angela@dovepress.com (Angela Jones)</webMaster><generator>Dove Press Gastrointestinal Cancer: Targets and Therapy</generator><image><title>Gastrointestinal Cancer: Targets and Therapy</title><link>https://www.dovepress.com/feed/journal/102</link><url>https://www.dovepress.com/assets/img/addon/rss-banner.jpg</url><width>140</width><height>140</height></image><item><title>Evidence for improvements to risk stratification in high-risk gastrointestinal stromal tumor patients</title><link>https://www.dovepress.com/evidence-for-improvements-to-risk-stratification-in-high-risk-gastroin-peer-reviewed-fulltext-article-GICTT</link><category>Gastrointestinal Cancer: Targets and Therapy</category><pubDate>Mon, 03 Dec 2018 14:07:00 +1300</pubDate><guid isPermaLink="true">https://doi.org/10.2147/GICTT.S145037</guid></item><item><title>Emerging treatment options for BRAF-mutant colorectal cancer</title><link>https://www.dovepress.com/emerging-treatment-options-for-braf-mutant-colorectal-cancer-peer-reviewed-fulltext-article-GICTT</link><category>Gastrointestinal Cancer: Targets and Therapy</category><pubDate>Thu, 22 Mar 2018 14:07:00 +1300</pubDate><guid isPermaLink="true">https://doi.org/10.2147/GICTT.S125940</guid></item><item><title>Models of intrahepatic cholangiocarcinoma: novel tools and therapeutic applications</title><link>https://www.dovepress.com/models-of-intrahepatic-cholangiocarcinoma-novel-tools-and-therapeutic--peer-reviewed-fulltext-article-GICTT</link><category>Gastrointestinal Cancer: Targets and Therapy</category><pubDate>Mon, 19 Feb 2018 13:30:00 +1300</pubDate><guid isPermaLink="true">https://doi.org/10.2147/GICTT.S115757</guid></item><item><title>Efficacy of trastuzumab beyond progression as second-line chemotherapy for HER2-positive advanced gastric cancer</title><link>https://www.dovepress.com/efficacy-of-trastuzumab-beyond-progression-as-second-line-chemotherapy-peer-reviewed-fulltext-article-GICTT</link><category>Gastrointestinal Cancer: Targets and Therapy</category><pubDate>Fri, 01 Dec 2017 14:27:00 +1300</pubDate><guid isPermaLink="true">https://doi.org/10.2147/GICTT.S145634</guid></item><item><title>Gastric neuroendocrine tumors: management and challenges</title><link>https://www.dovepress.com/gastric-neuroendocrine-tumors-management-and-challenges-peer-reviewed-fulltext-article-GICTT</link><category>Gastrointestinal Cancer: Targets and Therapy</category><pubDate>Fri, 29 Sep 2017 17:02:00 +1300</pubDate><guid isPermaLink="true">https://doi.org/10.2147/GICTT.S109028</guid></item><item><title>Current perspectives on hyperthermic intraperitoneal chemotherapy in gastric cancer</title><link>https://www.dovepress.com/current-perspectives-on-hyperthermic-intraperitoneal-chemotherapy-in-g-peer-reviewed-fulltext-article-GICTT</link><category>Gastrointestinal Cancer: Targets and Therapy</category><pubDate>Fri, 01 Sep 2017 14:12:00 +1200</pubDate><guid isPermaLink="true">https://doi.org/10.2147/GICTT.S139944</guid></item><item><title>Pancreatic cancer pain: impact and management challenges</title><link>https://www.dovepress.com/pancreatic-cancer-pain-impact-and-management-challenges-peer-reviewed-fulltext-article-GICTT</link><category>Gastrointestinal Cancer: Targets and Therapy</category><pubDate>Wed, 24 May 2017 17:03:00 +1200</pubDate><guid isPermaLink="true">https://doi.org/10.2147/GICTT.S95532</guid></item><item><title>PD-1 and PD-L1 as emerging therapeutic targets in gastric cancer: current evidence</title><link>https://www.dovepress.com/pd-1-and-pd-l1-as-emerging-therapeutic-targets-in-gastric-cancer-curre-peer-reviewed-fulltext-article-GICTT</link><category>Gastrointestinal Cancer: Targets and Therapy</category><pubDate>Fri, 05 May 2017 15:08:00 +1200</pubDate><guid isPermaLink="true">https://doi.org/10.2147/GICTT.S113525</guid></item><item><title>Optimal management of venous thromboembolism in advanced pancreatic cancer with low-molecular-weight heparin: current evidence</title><link>https://www.dovepress.com/optimal-management-of-venous-thromboembolism-in-advanced-pancreatic-peer-reviewed-fulltext-article-GICTT</link><category>Gastrointestinal Cancer: Targets and Therapy</category><pubDate>Mon, 31 Oct 2016 11:37:00 +1300</pubDate><guid isPermaLink="true">https://doi.org/10.2147/GICTT.S90695</guid></item><item><title>Therapeutic potential of mesenchymal stem cells in gastrointestinal cancers – current evidence</title><link>https://www.dovepress.com/therapeutic-potential-of-mesenchymal-stem-cells-in-gastrointestinal-ca-peer-reviewed-fulltext-article-GICTT</link><category>Gastrointestinal Cancer: Targets and Therapy</category><pubDate>Thu, 08 Sep 2016 14:30:00 +1200</pubDate><guid isPermaLink="true">https://doi.org/10.2147/GICTT.S54121</guid></item><item><title>Animal models of pancreatic cancer and their application in clinical research</title><link>https://www.dovepress.com/animal-models-of-pancreatic-cancer-and-their-application-in-clinical-r-peer-reviewed-fulltext-article-GICTT</link><category>Gastrointestinal Cancer: Targets and Therapy</category><pubDate>Thu, 25 Aug 2016 12:15:00 +1200</pubDate><guid isPermaLink="true">https://doi.org/10.2147/GICTT.S84531</guid></item><item><title>Spotlight on bevacizumab in metastatic colorectal cancer: patient selection and perspectives</title><link>https://www.dovepress.com/spotlight-on-bevacizumab-in-metastatic-colorectal-cancer-patient-selec-peer-reviewed-fulltext-article-GICTT</link><category>Gastrointestinal Cancer: Targets and Therapy</category><pubDate>Thu, 30 Jun 2016 11:27:00 +1200</pubDate><guid isPermaLink="true">https://doi.org/10.2147/GICTT.S97740</guid></item><item><title>Nab-paclitaxel plus gemcitabine in the treatment of metastatic pancreatic cancer: utility and experience from the clinic</title><link>https://www.dovepress.com/nab-paclitaxel-plus-gemcitabine-in-the-treatment-of-metastatic-pancrea-peer-reviewed-fulltext-article-GICTT</link><category>Gastrointestinal Cancer: Targets and Therapy</category><pubDate>Thu, 14 Jan 2016 13:46:00 +1300</pubDate><guid isPermaLink="true">https://doi.org/10.2147/GICTT.S82103</guid></item><item><title>Pancreatic cancer vaccine: a unique potential therapy</title><link>https://www.dovepress.com/pancreatic-cancer-vaccine-a-unique-potential-therapy-peer-reviewed-fulltext-article-GICTT</link><category>Gastrointestinal Cancer: Targets and Therapy</category><pubDate>Mon, 21 Dec 2015 13:59:00 +1300</pubDate><guid isPermaLink="true">https://doi.org/10.2147/GICTT.S55850</guid></item><item><title>Profile of lanreotide autogel and its potential in the treatment of gastroenteropancreatic neuroendocrine tumors</title><link>https://www.dovepress.com/profile-of-lanreotide-autogel-and-its-potential-in-the-treatment-of-ga-peer-reviewed-fulltext-article-GICTT</link><category>Gastrointestinal Cancer: Targets and Therapy</category><pubDate>Wed, 02 Sep 2015 13:55:00 +1200</pubDate><guid isPermaLink="true">https://doi.org/10.2147/GICTT.S70701</guid></item><item><title>Endoscopic radiofrequency ablation therapy for the prevention of esophageal cancer in Barrett’s esophagus</title><link>https://www.dovepress.com/endoscopic-radiofrequency-ablation-therapy-for-the-prevention-of-esoph-peer-reviewed-fulltext-article-GICTT</link><category>Gastrointestinal Cancer: Targets and Therapy</category><pubDate>Wed, 29 Jul 2015 14:09:00 +1200</pubDate><guid isPermaLink="true">https://doi.org/10.2147/GICTT.S55848</guid></item><item><title>The association between obesity and gastrointestinal cancer</title><link>https://www.dovepress.com/the-association-between-obesity-and-gastrointestinal-cancer-peer-reviewed-fulltext-article-GICTT</link><category>Gastrointestinal Cancer: Targets and Therapy</category><pubDate>Fri, 24 Jul 2015 13:45:00 +1200</pubDate><guid isPermaLink="true">https://doi.org/10.2147/GICTT.S55843</guid></item><item><title>Emerging role of microRNAs in the treatment of hepatocellular carcinoma</title><link>https://www.dovepress.com/emerging-role-of-micrornas-in-the-treatment-of-hepatocellular-carcinom-peer-reviewed-fulltext-article-GICTT</link><category>Gastrointestinal Cancer: Targets and Therapy</category><pubDate>Thu, 14 May 2015 12:00:00 +1200</pubDate><guid isPermaLink="true">https://doi.org/10.2147/GICTT.S44243</guid></item><item><title>The potential of targeted antiangiogenesis therapies in the treatment of esophageal cancer</title><link>https://www.dovepress.com/the-potential-of-targeted-antiangiogenesis-therapies-in-the-treatment--peer-reviewed-fulltext-article-GICTT</link><category>Gastrointestinal Cancer: Targets and Therapy</category><pubDate>Wed, 29 Apr 2015 14:51:00 +1200</pubDate><guid isPermaLink="true">https://doi.org/10.2147/GICTT.S49313</guid></item><item><title>Ramucirumab: hitting another target in gastric cancer</title><link>https://www.dovepress.com/ramucirumab-hitting-another-target-in-gastric-cancer-peer-reviewed-fulltext-article-GICTT</link><category>Gastrointestinal Cancer: Targets and Therapy</category><pubDate>Tue, 24 Feb 2015 13:46:00 +1300</pubDate><guid isPermaLink="true">https://doi.org/10.2147/GICTT.S41776</guid></item><item><title>Von Hippel-Lindau status influences phenotype of liver cancers arising from PTEN loss</title><link>https://www.dovepress.com/von-hippel-lindau-status-influences-phenotype-of-liver-cancers-arising-peer-reviewed-fulltext-article-GICTT</link><category>Gastrointestinal Cancer: Targets and Therapy</category><pubDate>Tue, 24 Feb 2015 13:14:00 +1300</pubDate><guid isPermaLink="true">https://doi.org/10.2147/GICTT.S72274</guid></item><item><title>Prospective prediction of resistance to neoadjuvant therapy in patients with locoregional esophageal adenocarcinoma</title><link>https://www.dovepress.com/prospective-prediction-of-resistance-to-neoadjuvant-therapy-in-patient-peer-reviewed-fulltext-article-GICTT</link><category>Gastrointestinal Cancer: Targets and Therapy</category><pubDate>Thu, 19 Feb 2015 11:57:00 +1300</pubDate><guid isPermaLink="true">https://doi.org/10.2147/GICTT.S75904</guid></item><item><title>New insights from animal models of colon cancer: inflammation control as a new facet on the tumor suppressor APC gem</title><link>https://www.dovepress.com/new-insights-from-animal-models-of-colon-cancer-inflammation-control-a-peer-reviewed-fulltext-article-GICTT</link><category>Gastrointestinal Cancer: Targets and Therapy</category><pubDate>Fri, 30 Jan 2015 14:04:00 +1300</pubDate><guid isPermaLink="true">https://doi.org/10.2147/GICTT.S51386</guid></item><item><title>EGFR signaling in colorectal cancer: a clinical perspective</title><link>https://www.dovepress.com/egfr-signaling-in-colorectal-cancer-a-clinical-perspective-peer-reviewed-fulltext-article-GICTT</link><category>Gastrointestinal Cancer: Targets and Therapy</category><pubDate>Mon, 19 Jan 2015 17:03:00 +1300</pubDate><guid isPermaLink="true">https://doi.org/10.2147/GICTT.S49002</guid></item><item><title>Nanoparticle albumin-bound (nab)-paclitaxel for the treatment of pancreas ductal adenocarcinoma</title><link>https://www.dovepress.com/nanoparticle-albumin-bound-nab-paclitaxel-for-the-treatment-of-pancrea-peer-reviewed-fulltext-article-GICTT</link><category>Gastrointestinal Cancer: Targets and Therapy</category><pubDate>Tue, 06 Jan 2015 13:41:00 +1300</pubDate><guid isPermaLink="true">https://doi.org/10.2147/GICTT.S55158</guid></item><item><title>Targeting cancer stem cells in hepatocellular carcinoma</title><link>https://www.dovepress.com/targeting-cancer-stem-cells-in-hepatocellular-carcinoma-peer-reviewed-fulltext-article-GICTT</link><category>Gastrointestinal Cancer: Targets and Therapy</category><pubDate>Wed, 17 Dec 2014 14:40:00 +1300</pubDate><guid isPermaLink="true">https://doi.org/10.2147/GICTT.S44250</guid></item><item><title>Esophageal cancer-related gene 4 at the interface of injury, inflammation, infection, and malignancy</title><link>https://www.dovepress.com/esophageal-cancer-related-gene-4-at-the-interface-of-injury-inflammati-peer-reviewed-fulltext-article-GICTT</link><category>Gastrointestinal Cancer: Targets and Therapy</category><pubDate>Fri, 24 Oct 2014 15:22:00 +1300</pubDate><guid isPermaLink="true">https://doi.org/10.2147/GICTT.S49085</guid></item><item><title>Targeting cancer stem cells in gastric cancer</title><link>https://www.dovepress.com/targeting-cancer-stem-cells-in-gastric-cancer-peer-reviewed-fulltext-article-GICTT</link><category>Gastrointestinal Cancer: Targets and Therapy</category><pubDate>Wed, 15 Oct 2014 12:28:00 +1300</pubDate><guid isPermaLink="true">https://doi.org/10.2147/GICTT.S48999</guid></item><item><title>STAT3 as an emerging molecular target in pancreatic cancer</title><link>https://www.dovepress.com/stat3-as-an-emerging-molecular-target-in-pancreatic-cancer-peer-reviewed-fulltext-article-GICTT</link><category>Gastrointestinal Cancer: Targets and Therapy</category><pubDate>Mon, 25 Aug 2014 15:12:00 +1200</pubDate><guid isPermaLink="true">https://doi.org/10.2147/GICTT.S48993</guid></item><item><title>Association between time to disease progression end points and overall survival in patients with neuroendocrine tumors</title><link>https://www.dovepress.com/association-between-time-to-disease-progression-end-points-and-overall-peer-reviewed-fulltext-article-GICTT</link><category>Gastrointestinal Cancer: Targets and Therapy</category><pubDate>Sat, 16 Aug 2014 00:00:00 +1200</pubDate><guid isPermaLink="true">https://doi.org/10.2147/GICTT.S61671</guid></item></channel></rss>
